Ticker LaunchFiled, not priced · MAVG
Medical 21, Inc.
Medical 21, Inc. publicly filed a registration statement on Form S-1 on Feb 19, 2026 for a proposed initial public offering under the ticker MAVG, and has not yet priced. Its latest amendment was filed on Mar 20, 2026. Underwriters named in the filing: ThinkEquity.
Medical 21, Inc. is a developmental-stage medical technology company working on coronary artery bypass grafting. Its MAVERICS small-diameter synthetic regenerative graft is an investigational alternative to harvested autologous vessels, intended to simplify the procedure.
- Status
- Filed, not priced
- Ticker
- MAVG
- First filed
- Feb 19, 2026
- Latest amendment
- Mar 20, 2026
- Underwriters
- ThinkEquity
- Sector
- Healthcare
- Country / state
- MN
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Feb 19, 2026
- Latest amendment Mar 20, 2026
- All filings on EDGAR CIK 1673688
Other companies in the IPO pipeline
- EIR Biopharma, Inc.Feb 17, 2026
- Hacker Interstellar Inc.Feb 13, 2026
- Solar Strategy Holdings LtdFeb 13, 2026
- Beta FinTech Holdings LtdFeb 12, 2026
- Hong qi bang bang kai man science & technology development Co., LtdFeb 11, 2026
- Xiamen Customized Elf Technology Co., Ltd.Feb 11, 2026